DCPH 13F Hedge Fund and Asset Management Owners

Data as of 2021-04-11 08:00:22 -0400
Market Cap	2.525 Billion	Shares Outstanding	57.626 Million	Avg 30-day Volume	354.422 Thousand
P/E Ratio		Dividend Yield		EPS
Price/Sales		Debt to Equity		EBITDA
Price to Book Value	0.0	Forward PE	-10.31	Enterprise Value
Total Cash		Current Debt		Gross Profit
BETA	1.28272	52-week High/Low	68.4 / 39.42	Next Earnings Date	2021-05-05	Price to Cash FLow (P/CF)	-37.6841
				Data provided by IEX Cloud

Q4 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	4	5	-20.0%	3 (0.18%)	4 (0.25%)	-25.0%
Funds Holding:	178	158	12.66%	63 (3.79%)	52 (3.24%)	21.15%
13F shares:	42.986 Million	41.878 Million	2.64%	17.796 Million	18.747 Million	-5.07%
% Ownership	75.5025	73.5569	2.65%	31.258	32.928	-5.07%
New Positions:	33	15	120.0%	18	8	125.0%
Increased Positions	69	62	11.29%	15	17	-11.76%
Closed Positions	11	21	-47.62%	6	13	-53.85%
Reduced Positions	49	53	-7.55%	21	18	16.67%
Total Calls	451.396 Thousand	445.3 Thousand	1.37%	292.46 Thousand	224.36 Thousand	30.35%
Total Puts	282.827 Thousand	425.598 Thousand	-33.55%	67.9 Thousand	208.072 Thousand	-67.37%
PUT/CALL Ratio	0.63	0.96	-34.37%	0.23	0.93	-75.27%
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding DCPH (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DCPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

31.9 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

30.7 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
BRISTOL JAMES ARTHUR	Director	29,150	2021-04-12	6
TAYLOR MICHAEL DOUGLAS	Director	2,354	2021-04-01	13
MARTIN DANIEL C. CHIEF COMMERCIAL OFFICER	Officer	27,702	2021-03-23	1
PITMAN JAMA SVP, REGULATORY & QUALITY	Officer	16,993	2021-03-23	1
HOERTER STEVEN L. PRESIDENT AND CEO	Officer Director	40,695	2021-03-18	8
KELLY THOMAS PATRICK CHIEF FINANCIAL OFFICER	Officer	17,616	2021-02-16	4
FLYNN DANIEL LEE CHIEF SCIENTIFIC OFFICER	Officer	339,087	2021-02-16	3
SHERMAN MATTHEW L EVP & CHIEF MEDICAL OFFICER	Officer	48,386	2021-02-16	4
WALSH DENNIS LEO	Director	0	2021-01-15	3
FRIEDMAN FRANKLIN STUART	Director	0	2021-01-15	3
SQUARER RON	Director	0	2021-01-15	3
KELLEY SUSAN L.	Director	0	2020-07-15	2
ALLEN PATRICIA L	Director	0	2020-06-10	2
BENZ EDWARD J. JR	Director	0	2020-06-10	1
MARTIN JOHN RICHARD	Director	0	2020-06-10	1
MORL CHRISTOPHER JOHN CHIEF BUSINESS OFFICER	Officer	0	2020-01-15	0
NEW LEAF VENTURE MANAGEMENT III, L.L.C. NEW LEAF VENTURES III, L.P. NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P. NEW LEAF VENTURE ASSOCIATES III, L.P. NEW LEAF BPO ASSOCIATES I, L.P.	10% Owner	7,708,280	2019-08-15	0
ROSS MICHAEL JAY	Director	0	2019-06-11	0
RUDDY STEPHEN B. CHIEF TECHNICAL OFFICER	Officer	0	2019-01-30	0
RATCLIFFE LIAM	Director 10% Owner	0	2018-05-17	0
BRIGHTSTAR ASSOCIATES LLC	10% Owner	16,572,370	2017-10-02	0
ROSEN OLIVER CHIEF MEDICAL OFFICER	Officer	0	2017-10-02	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
BRISTOL JAMES ARTHUR - Director	2021-04-14 16:00:20 -0400	2021-04-12	S	5,217	$44.09	d	0	direct	yes
BRISTOL JAMES ARTHUR - Director	2021-04-14 16:00:20 -0400	2021-04-12	S	9,483	$43.70	d	5,217	direct	yes
BRISTOL JAMES ARTHUR - Director	2021-04-14 16:00:20 -0400	2021-04-12	M	14,700		d	29,150	direct
BRISTOL JAMES ARTHUR - Director	2021-04-14 16:00:20 -0400	2021-04-12	M	14,700	$3.95	a	14,700	direct
TAYLOR MICHAEL DOUGLAS - Director	2021-04-06 06:00:31 -0400	2021-04-01	M	8,000		d	2,354	direct
TAYLOR MICHAEL DOUGLAS - Director	2021-04-06 06:00:31 -0400	2021-04-01	S	2,100	$44.80	d	5,900	direct	yes	-1.7757	-2.3601		0.0	1	-2.3601	6
TAYLOR MICHAEL DOUGLAS - Director	2021-04-06 06:00:31 -0400	2021-04-01	S	906	$46.72	d	0	direct	yes	-1.7757	-2.3601		0.0	1	-2.3601	6
TAYLOR MICHAEL DOUGLAS - Director	2021-04-06 06:00:31 -0400	2021-04-01	M	8,000	$1.89	a	8,000	direct		-1.7757	-2.3601		0.0	1	-2.3601	6
TAYLOR MICHAEL DOUGLAS - Director	2021-04-06 06:00:31 -0400	2021-04-01	S	4,994	$45.69	d	906	direct	yes	-1.7757	-2.3601		0.0	1	-2.3601	6
HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO	2021-03-22 17:00:12 -0400	2021-03-18	F	700	$42.39	d	43,145	direct	yes	-1.4456	-4.704		0.4589	4	-7.2969	5
HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO	2021-03-22 17:00:12 -0400	2021-03-18	F	2,450	$43.19	d	40,695	direct	yes	-1.4456	-4.704		0.4589	4	-7.2969	5
TAYLOR MICHAEL DOUGLAS - Director	2021-03-03 16:00:52 -0500	2021-03-01	S	6,896	$43.94	d	1,104	direct	yes	-0.3957	1.1755		1.1755	6	-5.9823	3
TAYLOR MICHAEL DOUGLAS - Director	2021-03-03 16:00:52 -0500	2021-03-01	M	8,000		d	10,354	direct
TAYLOR MICHAEL DOUGLAS - Director	2021-03-03 16:00:52 -0500	2021-03-01	M	8,000	$1.89	a	8,000	direct		-0.3957	1.1755		1.1755	6	-5.9823	3
TAYLOR MICHAEL DOUGLAS - Director	2021-03-03 16:00:52 -0500	2021-03-01	S	1,104	$44.68	d	0	direct	yes	-0.3957	1.1755		1.1755	6	-5.9823	3
HOERTER STEVEN L. - Director - Officer PRESIDENT AND CEO	2021-02-18 18:08:19 -0500	2021-02-16	A	210,000		d	210,000	direct
FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER	2021-02-18 19:00:23 -0500	2021-02-16	A	11,100		a	17,632	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER	2021-02-18 19:00:16 -0500	2021-02-16	A	11,100		a	48,386	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER	2021-02-18 19:00:25 -0500	2021-02-16	A	11,100		a	17,616	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER	2021-02-18 19:00:23 -0500	2021-02-16	S	508	$48.87	d	6,532	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER	2021-02-18 19:00:16 -0500	2021-02-16	S	132	$48.87	d	37,286	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER	2021-02-18 19:00:25 -0500	2021-02-16	S	524	$48.87	d	6,516	direct		-2.0468	-1.5295	3.5538	3.9361	21	-9.1543	12
FLYNN DANIEL LEE - Officer CHIEF SCIENTIFIC OFFICER	2021-02-18 19:00:23 -0500	2021-02-16	A	49,900		a	49,900	direct
SHERMAN MATTHEW L - Officer EVP & CHIEF MEDICAL OFFICER	2021-02-18 19:00:16 -0500	2021-02-16	A	49,900		a	49,900	direct
KELLY THOMAS PATRICK - Officer CHIEF FINANCIAL OFFICER	2021-02-18 19:00:25 -0500	2021-02-16	A	49,900		a	49,900	direct

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 22:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 21:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 21:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 20:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 20:15:04 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 19:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 19:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 18:45:02 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 18:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 17:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 17:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 16:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 16:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 15:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 15:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 14:45:02 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 14:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 13:45:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 13:15:03 UTC	-0.359	0.419	400000
DECIPHERA PHARMACEUTICALS IN DCPH	2021-04-14 12:45:03 UTC	-0.359	0.419	350000

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin
Trust for Professional Managers- Convergence Long/Short Equity Fund	DCPH	-424.0 shares, $-26203.2	2020-11-30	N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund	DCPH	-1514.0 shares, $-68145.14	2020-08-31	N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund	DCPH	-126.0 shares, $-5187.42	2020-03-31	N-PORT
FundVantage Trust- Gotham Defensive Long Fund	DCPH	-49.0 shares, $-2017.33	2020-03-31	N-PORT
FundVantage Trust- Gotham Master Neutral Fund	DCPH	-18.0 shares, $-923.4	2020-09-30	N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund	DCPH	-106.0 shares, $-4364.02	2020-03-31	N-PORT

Deciphera Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Deciphera Pharmaceuticals Inc (DCPH)

WhaleWisdom Alpha

Our Other Reporting & Analysis